Tirzepatide, a novel medication, is creating considerable excitement within the healthcare community. It works differently from existing diabetes therapies , targeting two receptors involved in blood regulation and appetite . Initial studies have demonstrated significant efficacy in reducing blood sugar in individuals with adult-onset diabetes and,